Institute of Biomedical Research and Innovation

Today, Japan is at a crossroads, confronted with a rapidly aging population, diminishing birth rates, a shrinking labor force, and increasing medical and nursing expenses for the elderly. Many Japanese are affected by cancer, senile dementia, diabetes, heart disease, cerebrovascular disease, and age-related functional disorders.
At the Institute of Biomedical Research and Innovation (IBRI), we consider that the way to overcome these challenges and open up a bright future for Japan is through realization of a society where people live longer while remaining healthy. Toward this goal, the IBRI carries out fundamental research mainly in the research areas of immunotherapy, brain and neurodegenerative disease, regenerative medicine, hematology– oncology and infectious disease; with research oriented toward the development of diagnostic and therapeutic methods.